Research output per year
Research output per year
Personal profile
Education
- 2007 Ph.D., The University of Utah
- 1999 M.S., Gwangju Institute of Science and Technology
- 1997 B.S., Hanyang University
- 1999 M.S., Gwangju Institute of Science and Technology
- 1997 B.S., Hanyang University
Professional Experience
- (2007-2023) Research Associate Professor of Pharmaceutics and Pharmaceutical Chemistry, The University of Utah
- (2011-present) Professor of Department of Pharmacy, The Catholic University of Korea
- (2014-present) Editoral Board Member, Acta Pharmaceutica Sinica B
- (2016-present) Associate Editor, Journal of Korean Chemical Society
- (2020-present) Editorial Board Member, Nano Convergence
- (2011-present) Professor of Department of Pharmacy, The Catholic University of Korea
- (2014-present) Editoral Board Member, Acta Pharmaceutica Sinica B
- (2016-present) Associate Editor, Journal of Korean Chemical Society
- (2020-present) Editorial Board Member, Nano Convergence
Research Interests
- Nanomedicine
- Nanoscale drug delivery
- Organelle-targeting
- Functionalized drug release
- Nanoscale drug delivery
- Organelle-targeting
- Functionalized drug release
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Han Chang Kang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Beyond Nanoparticle-Based Intracellular Drug Delivery: Cytosol/Organelle-Targeted Drug Release and Therapeutic Synergism
Cho, H., Huh, K. M., Shim, M. S., Cho, Y. Y., Lee, J. Y., Lee, H. S. & Kang, H. C., Jul 2024, In: Macromolecular Bioscience. 24, 7, 2300590.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Beyond nanoparticle-based oral drug delivery: transporter-mediated absorption and disease targeting
Cho, H., Huh, K. M., Cho, H. J., Kim, B., Shim, M. S., Cho, Y. Y., Lee, J. Y., Lee, H. S., Kwon, Y. J. & Kang, H. C., 19 Apr 2024, In: Biomaterials Science. 12, 12, p. 3045-3067 23 p.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Comparative metabolism of aschantin in human and animal hepatocytes
Lee, M. S., Shim, H. J., Cho, Y. Y., Lee, J. Y., Kang, H. C., Song, I. S. & Lee, H. S., Feb 2024, In: Archives of Pharmacal Research. 47, 2, p. 111-126 16 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Comparative metabolism of fargesin in human, dog, monkey, mouse, and rat hepatocytes
Lee, M. S., Park, E. J., Cho, Y. Y., Lee, J. Y., Kang, H. C. & Lee, H. S., Jan 2024, In: Toxicological Research. 40, 1, p. 125-137 13 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Dysregulated CREB3 cleavage at the nuclear membrane induces karyoptosis-mediated cell death
Lee, G. E., Bang, G., Byun, J., Lee, C. J., Chen, W., Jeung, D., An, H. J., Kang, H. C., Lee, J. Y., Lee, H. S., Hong, Y. S., Kim, D. J., Keniry, M., Kim, J. Y., Choi, J. S., Fanto, M., Cho, S. J., Kim, K. D. & Cho, Y. Y., Mar 2024, In: Experimental and Molecular Medicine. 56, 3, p. 686-699 14 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Press/Media
-
Studies from Catholic University of Korea Have Provided New Data on Hepatitis B Vaccines (Serologic Status and Vaccine Response Against Hepatitis B Virus After Allogeneic Hematopoietic Cell Transplantation In Pediatric Patients)
Jeong, D. C., Cho, B., Chung, N. G. & Kang, H. C.
6/06/23
1 item of Media coverage
Press/Media